Modification of Rapid Human Immunodeficiency Virus (HIV) Antibody Assay Protocols for Detecting Recent HIV Seroconversion
-
Published:2005-08
Issue:8
Volume:12
Page:918-921
-
ISSN:1556-6811
-
Container-title:Clinical and Vaccine Immunology
-
language:en
-
Short-container-title:Clin Vaccine Immunol
Author:
Soroka Stephen D.1, Granade Timothy C.1, Candal Debra1, Parekh Bharat S.1
Affiliation:
1. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
Abstract
ABSTRACT
Assay protocols of three rapid human immunodeficiency virus (HIV) assays, OraQuick-1/2, SeroStrip-1/2, and Determine-1/2, were modified to detect recent HIV seroconversion using a higher dilution of serum specimens. Optimal predilution of specimens resulted in negative test results during early periods of seroconversion (about 6 months), when antibody levels were low. A total of 269 seropositive specimens from routine HIV type 1 testing and from commercial sources (low-titer and seroconversion panels) were tested, and results were recorded as negative (score = 0) or positive using intensity scores from 0.5 (weak positive) to 4 (strongly positive). The same specimens were previously tested by a less sensitive (LS) enzyme immunoassay (EIA), Abbott 3A11-LS, and were classified as recent or long-term infections based on the standardized optical density (SOD) cutoff of 0.75. Overall concordance of >94% was observed between 3A11-LS and modified rapid tests (RT-LSs) for detecting and distinguishing recent HIV seroconversion from long-term HIV infection (kappa statistics = 0.894 to 0.901). Moreover, intensity scores on RT-LSs correlated well with median 3A11-LS SOD values (
R
2
> 0.98). Our results indicate that rapid HIV tests can be modified to detect recent seroconversion with results comparable to those from less sensitive EIA.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference17 articles.
1. Bulterys, M., A. Chao, A. Dushimimana, and B. S. Parekh. 2004. Unsafe injections and transmission of HIV-1 in sub-Sarahan Africa. Lancet363:1650. 2. Constantine, N. T., A. M. Sill, N. Jack, K. Kreisel, J. Edwards, T. Cafarella, H. Smith, C. Bartholomew, F. R. Cleghorn, and W. A. Blattner. 2003. Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. J. Acquir. Immune Defic. Syndr.32:94-103. 3. Downing, R. G., R. A. Otten, E. Marum, B. Biryahwaho, M. G. Alwano-Edyegu, S. D. Sempala, C. A. Fridlund, T. J. Dondero, C. Campbell, and M. A. Rayfield. 1998. Optimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithms. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.18:384-388. 4. Hu, D., Vanichseni S, Mock, P. A., Young, N. L., Dobbs, T., Byers, R., Choopanya, K., Griensven, F., Kitayaporn, D., McDougal, J. S., Tappero, J. W., Mastro, T. D., Parekh, B. S. 2003. HIV-1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG Capture BED enzyme immunoassay. AIDS Res. Hum. Retrovir.19:727-730. 5. Janssen, R. S., G. A. Satten, S. L. Stramer, B. D. Rawal, T. R. O'Brien, B. J. Weiblen, F. M. Hecht, N. Jack, F. R. Cleghorn, J. O. Kahn, M. A. Chesney, and M. P. Busch. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA280:42-48.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|